MATERIALISE NV
MTLSAbout the company
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations.
Investment snapshot
Positive
3
BUY / PASS
Neutral / negative
3 / 10
NEUTRAL / FAIL
Median fair value
$2.21
-65.9% vs price
Models with upside
0 / 17
Positive margin of safety
Strongest signal
10 of 12 pass — Marks and Asness object
Key risk
MTLS overvalued: all 9 models price fair value below $6.49 (median $2.21)
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | FAIL · Rank #1620 (Top 52.3%) | NEUTRAL | FAIL | FAIL | FAIL | FAIL | FAIL | PASS | NEUTRAL | PASS | BUY | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||
| Margin of Safety | -33.5% | N/A | -8.5% | -1019.0% | N/A | -308.2% | -193.7% | N/A | -153.5% | -1172.5% | -188.4% | -415.1% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2024 Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Market data at 2026-11-01 Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2024 Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2024 Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Market data at 2026-11-01 Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-04-22 Score computed: 2026-11-14 |
Where It Passes
- Debt & Leverage83% pass✓ 13✗ 2▾
10 of 12 pass — Marks and Asness object
LT Debt vs Net Current AssetsLT Debt $24.1M vs NCA $91.9M✓GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.17, IC: 7.3x✓BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.17✓Lynch< 0.33Cash - Long-term Debt$82.3M✓LynchPositive preferredLT Debt / Total Assets Change8.47% -> 5.85%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities1.86✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.17✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xDebt Levels0.17✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=7.3x, D/EBITDA=N/A (D&A unavailable)✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.17✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.1661; #1554/4210 (top 36.9%)✗AsnessTop 30% of eligible cross-section
Where It Falls Short
- Valuation models0% pass✗ 9▾
MTLS overvalued: all 9 models price fair value below $6.49 (median $2.21)
Graham fair value$4.86✗Graham-33.5% margin vs $6.49Lynch fair value$5.98✗Lynch-8.5% margin vs $6.49Greenblatt fair value$0.58✗Greenblatt-1019.0% margin vs $6.49Dreman fair value$1.59✗Dreman-308.2% margin vs $6.49Munger fair value$2.21✗Munger-193.7% margin vs $6.49Akre fair value$2.56✗Akre-153.5% margin vs $6.49Marks fair value$0.51✗Marks-1172.5% margin vs $6.49Ackman fair value$2.25✗Ackman-188.4% margin vs $6.49Templeton fair value$1.26✗Templeton-415.1% margin vs $6.49 - Valuation8% pass✓ 5✗ 23▾
12 of 13 flag MTLS's valuation — Graham, Greenblatt, Dreman +9 more
Price / Book Value per Share1.5x✗Dreman< 1.2x✓Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Price / 3-yr avg EPS61.1x✗Graham<= 15xPrice-to-Book Ratio1.5x✓Graham<= 1.5xP/E x P/B90.60✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)0.58✓Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value3.2%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=3.2%, ROC=8.2%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS27.1x✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)11.7x✗Dreman< 8xValuation ReasonablenessP/E=27.1x✗MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=27.1x, FCF Yield=1.9%✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=27.1x, P/B=1.5x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-307.6% (IV=$1.59 vs Price=$6.49)✗Marks>= 20% below intrinsic valuePrice / FCF per Share54.1x✗Ackman<= 25Price vs. Trailing Low132% of trailing low ($4.92)✗Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization+3.78%; #2102/6340 (top 33.2%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+0.6993; #2205/6449 (top 34.2%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS27.1x✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share2.10x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change+49.0%✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.7504; #2121/5247 (top 40.4%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+1.91%; #2261/4519 (top 50.0%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date+28.01%; #1070/6202 (top 17.3%)✗OshaughnessyTop 10% of eligible cross-section - Profitability13% pass✓ 11✗ 24▾
14 of 16 flag MTLS's profitability — Graham, Buffett, Lynch +11 more
Positive EPS (10 years)5/10 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growthNet Income Positive (10+ years)5/10 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)1.5%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)3.5% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy✗BuffettPositive and growingEarnings Variance (10-yr CoV)3.71✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)0.58✓Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR46.7%✓Lynch15-30% (Fast Grower); > 0% to passROE5.4%✗Lynch> 15%EBIT / Enterprise Value3.2%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=3.2%, ROC=8.2%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets3.39%✓PiotroskiROA > 0ROA Change YoY1.69% -> 3.39% (delta: +1.70%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=7.94%, ROA=3.39%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY56.7% -> 56.5%✗PiotroskiImproved YoYPre-Tax Income / Revenue5.3%✗Dreman>= 8%Net Income / Shareholders' Equity5.4%✗Dreman> 12%Margin of SafetyP/E=27.1x, P/B=1.5x✓PabraiP/B < 1.5 or P/E < 15Return on Equity2.4% (3-yr avg)✗AkreROE > 20% (3-year avg)Discount to Intrinsic Value-307.6% (IV=$1.59 vs Price=$6.49)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency5/10 years positive✗MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue3.5%✗Ackman>= 15%Net Income / Shareholders Equity5.4%✗Ackman>= 15%5-Year EPS CAGR46.7% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Operating Margin Trend-1.2% (2022) -> 3.5% (2024)✓TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 55.5% -> 56.5%, operating margin -1.2% -> 3.5%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization+3.78%; #2102/6340 (top 33.2%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+38.06%; #1026/3702 (top 27.7%)✓AsnessTop 30% of eligible cross-sectionNet income / positive book equity+5.41%; #2413/5226 (top 46.2%)✗AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0215; #1532/5884 (top 26.0%)✓AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR46.7% over 5 years✗Neff7%-20% annualizedPositive Diluted-EPS Years5/10 years positive✗Schloss>= 70% positive over 5-10 observed years (app rule) - Efficiency13% pass✓ 2✗ 9▾
7 of 8 flag MTLS's efficiency — Graham, Buffett, Greenblatt +4 more
Current Ratio1.86✗Graham>= 2.0ROIC (3-5 yr avg)1.9%✗Buffett> 10%ROIC - WACC-8.1%✗BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)8.2%✗Greenblatt> 25%Current Ratio Change YoY1.97 -> 1.86✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.65x -> 0.67x✓PiotroskiImproved YoYCurrent Assets / Current Liabilities1.86✓Dreman> 1.5Return on Invested Capital2.6%✗Munger> 15%ROIC (high and growing)FY2022: ROIC=-0.7%; FY2023: ROIC=1.5%; FY2024: ROIC=2.6%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC2.6% (RR=100% x ROIC=2.6%)✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)0/5 years above 12% (latest 2.6%)✗SleepROIC > 12% in a majority of years - Verdicts21% pass✓ 3✗ 11▾
Split decision: 10 FAIL · 3 NEUTRAL · 2 PASS · 1 BUY
Overall verdict✗GrahamFAIL (3/9)✗BuffettFAIL (2/9)✗LynchFAIL (4/7)✗GreenblattRank #1620•PiotroskiNEUTRAL (F-Score 7)✗DremanFAIL (4/11)✗MungerFAIL (1/4)✗PabraiFAIL (1/3)✗AkreFAIL (2/6)✗MarksFAIL (2/5)✓AckmanPASS (4/9)•TempletonNEUTRAL (5/8)✓SleepPASS (3/6)✓AsnessBUY (Rank #156/2370 (Top 6.6%))✗NeffFAIL (2/6)✗SchlossFAIL (3/7)•OshaughnessyNEUTRAL (Not ranked) - Growth38% pass✓ 7✗ 6▾
5 of 8 flag MTLS's growth — Graham, Lynch, Marks +2 more
EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)0.58✓Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR46.7%✓Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue Growth✗LynchInventory growth < Revenue growthEPS Growth Direction$-0.07 (2015) -> $0.24 (2024)✓DremanPositive over recent yearsEPS CAGR23.1% CAGR over 6 years✓Dreman> 5% annualizedPositive Net Income Frequency5/10 years positive✗MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth6.3%✓Ackman>= 5%Positive EPS Growth Frequency3/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR46.7% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 55.5% -> 56.5%, operating margin -1.2% -> 3.5%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR4.7%✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR46.7% over 5 years✗Neff7%-20% annualized - Cash Flow40% pass✓ 5✗ 7▾
6 of 10 flag MTLS's cash flow — Buffett, Lynch, Dreman +3 more
Free Cash Flow Proxy✗BuffettPositive and growingFCF Positive and Growing$7.1M✗LynchPositive and growingOperating Cash Flow$32.7M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=7.94%, ROA=3.39%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)11.7x✗Dreman< 8xP/E or FCF YieldP/E=27.1x, FCF Yield=1.9%✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive6/6 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap1.8%✗Ackman>= 4%Price / FCF per Share54.1x✗Ackman<= 25Positive Operating Cash Flow frequency6/6 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$7.1M✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+1.91%; #2261/4519 (top 50.0%)✗OshaughnessyTop 10% of eligible cross-section
Business & financials
Financial snapshot: annual FY 2024. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2024
Retired 0.0% of shares last year, 0.0% over two.
- Buybacks
- —
- Dividends
- —
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
| Metric | FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
| FY 2020Sources
|
|---|---|---|---|---|---|
| Market Cap | $369.9Mcurrent | $334.9Mest. | $622.6Mest. | $1.2Best. | $3.5Best. |
| Revenue | $277.6M↓2% | $283.5M↑15% | $247.4M↑6% | $232.7M↑11% | $209.7M |
| Operating Income | $9.8M↑58% | $6.2M↑303% | -$3.1M↓122% | $13.8M↑343% | -$5.7M |
| Net Income | $14.0M↑88% | $7.4M↑429% | -$2.3M↓115% | $14.9M↑272% | -$8.7M |
| EPS (Diluted) | $0.24↑97% | $0.12↑386% | $-0.04↓116% | $0.26↑259% | $-0.16 |
| Gross Margin | 56.5% | 56.7%↑2% | 55.5%↓4% | 57.5%↑4% | 55.2% |
| Operating Margin | 3.5%↑61% | 2.2%↑277% | -1.2%↓121% | 5.9%↑319% | -2.7% |
| ROE | 5.4%↑90% | 2.8%↑406% | -0.9%↓116% | 5.7%↑207% | -5.3% |
| Total Debt | $43.0M↓34% | $65.4M↓19% | $80.9M↓28% | $112.2M↓21% | $141.6M |
| Shareholders' Equity | $258.7M↓1% | $261.9M↑7% | $244.1M↓7% | $263.4M↑61% | $163.8M |
| Current Ratio | 1.86↓5% | 1.97↓4% | 2.04↓28% | 2.82↑48% | 1.90 |
| Debt / Equity | 0.17↓33% | 0.25↓25% | 0.33↓22% | 0.43↓51% | 0.86 |
| Operating Cash Flow | $32.7M↑47% | $22.3M↓6% | $23.8M↓19% | $29.3M↓21% | $36.9M |
| Free Cash Flow | $7.1M↓41% | $12.1M↑1568% | $724.9K↓96% | $20.3M↓13% | $23.3M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Business Services
MTLS vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AUTOMATIC DATA PROCESSING INCADP | $122.3B | $309.93 | $21.9B | $4.4B | 73.2% | 0.82 | 24.2% | 1.05 | 4/9 | 5/9 | 3/7 | 0/3 | F-Score 6 | 5/11 |
| ELECTRONIC ARTS INC.EA | $52.9B | $209.70 | $7.5B | $887.0M | 13.1% | 0.22 | 15.4% | 1.05 | 1/9 | 4/9 | 4/7 | 0/3 | F-Score 6 | 6/11 |
| Rubrik, Inc.RBRK | $22.6B | $109.88 | $1.3B | $348.8M | 67.1% | — | -26.2% | 1.69 | 1/9 | 0/9 | 2/7 | 0/3 | F-Score 6 | 2/11 |
| AECOMACM | $9.1B | $70.50 | $16.1B | $561.8M | 22.5% | 1.09 | 6.4% | 1.14 | 1/9 | 3/9 | 3/7 | 1/3 | F-Score 8 | 2/11 |
| COMMVAULT SYSTEMS INCCVLT | $6.2B | $152.07 | $1.2B | $70.7M | 942.8% | — | 6.3% | 1.95 | 1/9 | 2/9 | 4/7 | 0/3 | F-Score 6 | 6/11 |
| WPP plcWPP | $6.0B | $27.79 | $18.2B | $289.5M | -8.5% | 1.94 | 2.8% | 0.89 | 1/9 | 2/9 | 1/7 | 0/3 | F-Score 3 | 2/11 |
| VARONIS SYSTEMS INCVRNS | $5.6B | $48.94 | $623.5M | $129.3M | -21.6% | 0.76 | -23.5% | 1.97 | 1/9 | 0/9 | 1/7 | 0/3 | F-Score 5 | 1/11 |
| ROBERT HALF INC.RHI | $4.3B | $42.00 | $5.4B | $133.0M | 10.4% | — | 1.4% | 1.53 | 2/9 | 5/9 | 1/7 | 0/3 | F-Score 5 | 2/11 |